President Trump’s critical comments on trade relations with China led to a sell-off in the stock market. China’s export controls on rare earth minerals intensified the trade war, causing concerns about supply chain disruptions and higher costs for tech companies. Among the impacted stocks, AMN Healthcare Services experienced volatility but was not fundamentally affected. The Trump administration’s drug-pricing initiative, including Pfizer’s agreement to sell medications at reduced prices, received positive market reaction. AMN Healthcare Services is down 25.9% this year, trading 57.1% below its 52-week high. Investors are optimistic about the semiconductor stock benefiting from AI technology.

Read more at Barchart: 10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know